News Focus
News Focus
Followers 62
Posts 4655
Boards Moderated 0
Alias Born 04/23/2013

Re: Whalatane post# 374816

Tuesday, 04/12/2022 4:31:08 PM

Tuesday, April 12, 2022 4:31:08 PM

Post# of 447408
I don't know what his lipids would have been otherwise, but I do know that at least 50% of first time MACE's are in people with normal lipids. We are learning that the MOA's for CVD prevention go well beyond lipid management. I recall the recently posted CAC score by PharmacyDude (who otherwise has normal lipids) is a good example of the fallibility of lipid testing. Besides, VASCEPA has many other pleotropic effects that don't show up on the label. Another point: The VASCEPA label doesn't call for "fasting" Trigs, so yes I'm ok with it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News